HIGHLIGHTS
- who: Mengmeng Li from the PTC Therapeutics, United States Sichuan University, China have published the article: Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib, in the Journal: (JOURNAL) of September/29,/2022
- what: We described a typical EIMS case with a round or epithelioid morphology of cells, accompanied by a high relapse and a poor prognosis.
- future: Given the lack of the clear resistance mechanisms further research is needed.
SUMMARY
Inflammatory myofibroblastic tumor (IMT) is as an intermediate soft tissue tumor composed of myofibroblast-differentiated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.